TGFB1 and type 2 diabetes mellitus: NAC treatment effectively suppressed excessive ROS production, partially attenuated TGF-β expression, and significantly decreased tissue fibrosis in the ischemic limb muscle in T2D mice without significant changes in the levels of plasma AGEs and blood glucose.